INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 41 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3 | -99.9% | 4,000 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q3 2020 | $3,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q2 2020 | $3,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -25.0% | 4,000 | 0.0% | 0.00% | – |
| Q4 2019 | $4,000 | +33.3% | 4,000 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | -25.0% | 4,000 | 0.0% | 0.00% | – |
| Q2 2019 | $4,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|